← Back to Search

MMprofiler for Multiple Myeloma (PROMMIS Trial)

N/A

Waitlist Available

Led By Saad Usmani, MD

Research Sponsored by SkylineDx

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Must not have

ECOG Performance Status > 3

Timeline

Screening 3 weeks

Treatment Varies

Follow Up treatment intention is measured before mmprofiler sky92 and within 4 weeks after mmprofiler

Awards & highlights

No Placebo-Only Group

Summary

This trial will study whether a new tool called MMprofiler can help make treatment decisions for Multiple Myeloma patients.

Who is the study for?

This trial is for individuals who may have multiple myeloma based on IMWG criteria and are candidates for systemic treatment. Participants must be able to perform daily activities with relative ease (ECOG Performance Status ≤ 3). They cannot join if their tumor samples fail quality assessments for the MMprofiler test.

What is being tested?

The study is examining how the MMprofiler, which analyzes a specific gene signature in multiple myeloma patients, affects doctors' decisions about treatment plans. It's an observational study focusing on whether this genetic test influences treatment strategies.

What are the potential side effects?

Since this trial involves a diagnostic procedure rather than a drug or therapy, there are no direct side effects from interventions like those seen with medications. However, standard risks associated with medical procedures such as discomfort or bruising at the biopsy site may occur.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I am mostly bedridden due to my health condition.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ treatment intention is measured before mmprofiler sky92 and within 4 weeks after mmprofiler

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~treatment intention is measured before mmprofiler sky92 and within 4 weeks after mmprofiler

This trial's timeline: 3 weeks for screening, Varies for treatment, and treatment intention is measured before mmprofiler sky92 and within 4 weeks after mmprofiler for reporting.